Comment on “Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US”
Sign Up to like & getrecommendations! Published in 2020 at "PharmacoEconomics"
DOI: 10.1007/s40273-020-00975-7
Abstract: In the 12 June, 2020 issue of this journal, William Padula and others undertake an assessment of the impact of orphan drug exclusivity in the article: “Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017)… read more here.
Keywords: exclusivity; budget impact; orphan approvals; multiple orphan ... See more keywords